Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Francis Leo Delmonico, M.D.

Co-Author

This page shows the publications co-authored by Francis Delmonico and A. Cosimi.
Connection Strength

2.716
  1. Anti-CD4 monoclonal antibody therapy. Clin Transplant. 1996 Oct; 10(5):397-403.
    View in: PubMed
    Score: 0.170
  2. Second renal transplantations. Ethical issues clarified by outcome; outcome enhanced by a reliable crossmatch. Arch Surg. 1994 Apr; 129(4):354-60.
    View in: PubMed
    Score: 0.143
  3. Management of the renal allograft recipient: immunosuppressive protocols for long-term success. Clin Transplant. 1994 Feb; 8(1):34-9.
    View in: PubMed
    Score: 0.141
  4. Nonhuman primate response to murine and humanized monoclonal antibodies. Transplant Proc. 1993 Apr; 25(2 Suppl 1):65-7.
    View in: PubMed
    Score: 0.133
  5. Immunosuppression of cynomolgus renal allograft recipients with humanized OKT4A monoclonal antibodies. Transplant Proc. 1993 Feb; 25(1 Pt 1):784-5.
    View in: PubMed
    Score: 0.132
  6. Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease. Transplantation. 2011 Mar 27; 91(6):672-6.
    View in: PubMed
    Score: 0.116
  7. Long-term, low-dose cyclosporine treatment of renal allograft recipients. A randomized trial. Transplantation. 1990 May; 49(5):899-904.
    View in: PubMed
    Score: 0.109
  8. 1,000 renal transplants at the Massachusetts General Hospital: improved allograft survival for high-risk patients without regard to HLA matching. Clin Transpl. 1990; 247-53.
    View in: PubMed
    Score: 0.106
  9. Promotion of altruistic donation. Transplantation. 2009 Sep 27; 88(6):847.
    View in: PubMed
    Score: 0.105
  10. Simultaneous procurement of pancreas and liver from a single cadaveric donor. Transplant Proc. 1989 Jun; 21(3):3521.
    View in: PubMed
    Score: 0.102
  11. Variation in patient response associated with different preparations of murine monoclonal antibody therapy. Transplantation. 1989 Jan; 47(1):92-5.
    View in: PubMed
    Score: 0.099
  12. Monoclonal antibody treatment of human allograft recipients. Surg Gynecol Obstet. 1988 Jan; 166(1):89-98.
    View in: PubMed
    Score: 0.093
  13. The selective use of antilymphocyte serum for cyclosporine treated patients with renal allograft dysfunction. Ann Surg. 1987 Nov; 206(5):649-54.
    View in: PubMed
    Score: 0.092
  14. A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation. 2003 Sep 15; 76(5):798-802.
    View in: PubMed
    Score: 0.069
  15. Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation. 2002 Nov 27; 74(10):1405-9.
    View in: PubMed
    Score: 0.065
  16. The kidney transplant program at the Massachusetts general hospital. Clin Transpl. 2001; 123-30.
    View in: PubMed
    Score: 0.057
  17. Twenty-year Follow-up of Histocompatibility Leukocyte Antigen-matched Kidney and Bone Marrow Cotransplantation for Multiple Myeloma With End-stage Renal Disease: Lessons Learned. Transplantation. 2019 11; 103(11):2366-2372.
    View in: PubMed
    Score: 0.053
  18. Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation. 1999 Aug 27; 68(4):480-4.
    View in: PubMed
    Score: 0.052
  19. Evolving trends in liver transplantation: an outcome and charge analysis. Transplantation. 1999 Jan 27; 67(2):246-53.
    View in: PubMed
    Score: 0.050
  20. Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. Transplantation. 1998 Dec 15; 66(11):1460-4.
    View in: PubMed
    Score: 0.050
  21. Contribution of native kidney function to total glomerular filtration rate after combined kidney-pancreas transplantation. Transplantation. 1998 Jan 15; 65(1):99-103.
    View in: PubMed
    Score: 0.046
  22. Selective use of veno-venous bypass in orthotopic liver transplantation. Clin Transplant. 1996 Apr; 10(2):181-5.
    View in: PubMed
    Score: 0.041
  23. CDR-grafted OKT4A monoclonal antibody in cynomolgus renal allograft recipients. Transplantation. 1994 Mar 27; 57(6):788-93.
    View in: PubMed
    Score: 0.036
  24. Nonhuman primate responses to murine and humanized OKT4A. Transplantation. 1993 Apr; 55(4):722-8.
    View in: PubMed
    Score: 0.033
  25. A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation. 1993 Apr; 55(4):766-72; discussion 772-3.
    View in: PubMed
    Score: 0.033
  26. Liver transplantation for primary hepatic cancer. Transplantation. 1992 Feb; 53(2):376-82.
    View in: PubMed
    Score: 0.031
  27. Long-term metabolic and quality of life results with pancreatic/renal transplantation in insulin-dependent diabetes mellitus. Transplantation. 1991 Jul; 52(1):85-91.
    View in: PubMed
    Score: 0.030
  28. OKT4A monoclonal antibody immunosuppression of cynomolgus renal allograft recipients. Transplant Proc. 1991 Feb; 23(1 Pt 1):501-3.
    View in: PubMed
    Score: 0.029
  29. Changing pattern of organ donation at a single center: are potential brain dead donors being lost to donation after cardiac death? Am J Transplant. 2010 Nov; 10(11):2536-40.
    View in: PubMed
    Score: 0.028
  30. Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody. Surgery. 1990 Aug; 108(2):406-13; discussion 413-4.
    View in: PubMed
    Score: 0.028
  31. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J Immunol. 1990 Jun 15; 144(12):4604-12.
    View in: PubMed
    Score: 0.027
  32. A randomized clinical trial of prophylactic OKT3 monoclonal antibody in liver allograft recipients. Arch Surg. 1990 Jun; 125(6):781-4; discussion 785.
    View in: PubMed
    Score: 0.027
  33. Cure of hemophilia A by orthotopic liver transplantation. Gastroenterology. 1988 Jul; 95(1):192-4.
    View in: PubMed
    Score: 0.024
  34. Combined kidney and pancreas transplantation in diabetics. Arch Surg. 1988 May; 123(5):621-5.
    View in: PubMed
    Score: 0.024
  35. Impact of donor kidney recovery method on lymphatic complications in kidney transplantation. Transplant Proc. 2008 May; 40(4):1054-5.
    View in: PubMed
    Score: 0.024
  36. Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: realities and costs. Am J Transplant. 2007 Dec; 7(12):2769-74.
    View in: PubMed
    Score: 0.023
  37. A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection. Transplant Proc. 1987 Feb; 19(1 Pt 3):2431-3.
    View in: PubMed
    Score: 0.022
  38. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant. 2006 Sep; 6(9):2121-33.
    View in: PubMed
    Score: 0.021
  39. Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation. Transpl Int. 2005 May; 18(5):532-40.
    View in: PubMed
    Score: 0.019
  40. Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction. Clin Transplant. 2004 Aug; 18(4):341-8.
    View in: PubMed
    Score: 0.018
  41. Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients. Transplantation. 2004 Apr 27; 77(8):1199-202.
    View in: PubMed
    Score: 0.018
  42. A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation. Transplantation. 2003 May 15; 75(9):1501-5.
    View in: PubMed
    Score: 0.017
  43. Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy. Am J Transplant. 2003 Jan; 3(1):74-8.
    View in: PubMed
    Score: 0.016
  44. Tacrolimus-associated posttransplant diabetes mellitus in renal transplant recipients: role of hepatitis C infection. Transplant Proc. 2002 Aug; 34(5):1771-73.
    View in: PubMed
    Score: 0.016
  45. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol. 2002 Mar; 13(3):779-787.
    View in: PubMed
    Score: 0.015
  46. Managing the highly sensitized transplant recipient and B cell tolerance. Curr Opin Immunol. 2001 Oct; 13(5):577-81.
    View in: PubMed
    Score: 0.015
  47. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection. Transplantation. 2001 Jul 15; 72(1):77-83.
    View in: PubMed
    Score: 0.015
  48. Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. Transplantation. 2001 Mar 15; 71(5):652-8.
    View in: PubMed
    Score: 0.014
  49. The clinical usefulness of the renal allograft biopsy in the cyclosporine era: a prospective study. Transplantation. 1999 Mar 15; 67(5):737-41.
    View in: PubMed
    Score: 0.013
  50. In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients. Transplantation. 1999 Jan 27; 67(2):253-8.
    View in: PubMed
    Score: 0.012
  51. Renal thrombotic microangiopathy associated with anticardiolipin antibodies in hepatitis C-positive renal allograft recipients. J Am Soc Nephrol. 1999 Jan; 10(1):146-53.
    View in: PubMed
    Score: 0.012
  52. De novo collapsing glomerulopathy in renal allografts. Transplantation. 1998 May 15; 65(9):1192-7.
    View in: PubMed
    Score: 0.012
  53. Humanized IgG1 and IgG4 anti-CD4 monoclonal antibodies: effects on lymphocytes in the blood, lymph nodes, and renal allografts in cynomolgus monkeys. Transplantation. 1998 Mar 15; 65(5):632-41.
    View in: PubMed
    Score: 0.012
  54. Trimethoprim-sulfamethoxazole compared with ciprofloxacin for the prevention of urinary tract infection in renal transplant recipients. A double-blind, randomized controlled trial. Online J Curr Clin Trials. 1992 Aug 11; Doc No 15:[4083 words; 46 paragraphs].
    View in: PubMed
    Score: 0.008
  55. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation. 1992 Jan; 53(1):68-72.
    View in: PubMed
    Score: 0.008
  56. Successful treatment of invasive fungal infection with fluconazole in organ transplant recipients. Transplantation. 1989 Oct; 48(4):692-5.
    View in: PubMed
    Score: 0.007
  57. Renal transplantation in the highly sensitized recipient. Transplant Proc. 1987 Feb; 19(1 Pt 1):769-70.
    View in: PubMed
    Score: 0.005
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.